Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 220 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
86 Мб
Скачать
330
https://t.me/medicina_free
12 Symptomatic Uterine Myoma
97. Sesti F, Capozzolo T, etal. Isobaric gasless lapa­roscopy versus minilaparotomy in uterine myo­mectomy: a randomized trial. Surg Endosc. 2008;22:917–23.
98. Ortaç M, Sonmezer MFG. Myomectomy dur­ing caesarean section. Int J Gynecol Obstet. 1999;67:189–90.
99. Song D, Zhang W, Chames MC, Guo J.Myomectomy during cesarean delivery. Int J Gynecol Obstet. 2013;121:208–13.
100. Sparic R, Malvasi A, Kadija S, Babovic I, Nejkovic L, Tinelli A.Cesarean myomectomy trends and con­troversies: an appraisal. J Matern Fetal Neonatal Med. 2017;30:1114–23.
101. Sparic R.Intraoperative hemorrhage as a complica­tion of cesarean myomectomy: analysis of risk fac­tors. Vojnosanitetski Pregl. 2016;73:415–21.
102. Vilos GA, Allaire C, Laberge PY, Leyland N. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37:157–78.
103. Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN, Doumouchtsis SK. Perioperative com­plications of cesarean delivery myomectomy: a meta-analysis. Obstet Gynecol. 2017;130:1295–303.
104. Sparic R, Papoutsis D, Bukumiric Z, Kadija S, Spremovic Radjenovic S, Malvasi A, etal. The inci­dence of and risk factors for complications when removing a single uterine broid during cesar­ean section: a retrospective study with use of two comparison groups. J Matern Fetal Neonatal Med. 2020;33(19):3258–65.
105. Akbas M, Mihmanli V, Bulut B, Temel Yuksel I, Karahisar G, Demirayak G. Myomectomy for intramural broids during caesarean section: a therapeutic dilemma. J Obstet Gynaecol (Lahore). 2017;37:141–5.
106. Umezurike C, Akwuruoha E, Eguzo K. A cohort study of maternal and fetal outcomes for myomec­tomy at caesarean section in aba, south eastern Nigeria. Int J Reprod Contracept Obstet Gynecol. 2014;3:936–41.
107. Kwawukume EY. Myomectomy during cesarean section. Int J Gynecol Obstet. 2002;76:183–4.
108. Li H, Du J, Jin L, Shi Z, Liu M.Myomectomy dur­ing cesarean section. Acta Obstet Gynecol Scand. 2009;88:183–6.
109. Ehigiegba AE, Ande AB, Ojobo SI.Myomectomy during cesarean section. Int J Gynecol Obstet. 2001;75:21–5.
110. Eyong E, Okon OA.Large uterine broids in preg­nancy with successful caesarean myomectomy. Case Rep Obstet Gynecol. 2020;2020:8880296.
111. Hatirnaz S, Güler O, Basarano Glu S.Endometrial myomectomy: a novel surgical method during cesarean section. J Matern Fetal Neonatal Med. 2018;31:433–8.
112. Incebiyik A, Hilali N, A AC.Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet. 2014;289:569–73.
113. Park BJ, Kim YW.Safety of cesarean myomectomy. J Obstet Gynaecol Res. 2009;35(5):906–11.
114. Rosati C, Mancuso SPE. Longitudinal evalu­ation of uterine myoma growth during preg­nancy. A sonographic study. J Ultrasound Med. 1992;11:511–5.
115. Degani S, Tamir A, Leibovitz Z, Shapiro I, Gonen R, Ohel G.Three-dimensional power Doppler in the evaluation of painful leiomyomas and focal uter­ine thickening in pregnancy. Int J Gynecol Obstet. 2007;99:122–6.
116. Michalas SP, Oreopoulou FV, Papageorgiou JS. Myomectomy during pregnancy and caesarean section. Hum Reprod. 1995;10:1869–70.
117. Benson CB, Chow JS, Chang-Lee W, Hill JA, Doubilet PM. Outcome of pregnancies in women with uterine leiomyomas identied by sonog­raphy in the rst trimester. J Clin Ultrasound. 2001;29(5):261–4.
118. Glavind K, Palvio DH, Lauritsen JG. Uterine myoma in pregnancy. Acta Obstet Gynecol Scand. 1990;69(7–8):617–9.
119. Mollica L, Minganti E, etal. Elective uterine myo­mectomy in pregnant women. Clin Exp Obstet Gynecol. 1996;23:168–72.
120. Lee HJ, Norwitz ER, Shaw J.Contemporary man­agement of broids in pregnancy. Rev Obstet Gynecol. 2010;3(1):20.
121. Chuang J, Tsai HW, Hwang JL, Wu K, Su H, Hospital M, et al. Fetal compression syndrome caused by myoma in pregnancy: A case report. Acta Obstet Gynecol Scand. 2001;80(5):472–3.
122. Graham JM, Miller ME, Stephan MJ, Smith DW. Limb reduction anomalies and early in utero limb compression. J Pediatr. 1980;96(6): 1052–6.
123. Romero R, Chervenak FA, DeVore G, Tortora M, Hobbins JC. Fetal head deformation and congeni­tal torticollis associated with a uterine tumor. Am J Obstet Gynecol. 1981;141(7):839–40.
124. Joó JG, Inovay J, Silhavy M, Papp Z.Successful enucleation of a necrotizing broid causing oligo­hydramnios and fetal postural deformity in the 25th week of gestation. A case report. J Reprod Med. 2001;46(10):923–5.
Complicated Pelvic Inammatory
https://t.me/medicina_free
Disease
13
Abstract
Pelvic inammatory disease is rare during pregnancy. The most obvious reason is that many pregnancies are more or less desired, and one of the preparations is the prepreg­nancy treatment of any disease, especially of reproductive organs. Pregnancy is said to pro­tect against pelvic infections, and clinicians are unlikely to suspect complicated pelvic inammatory disease as a cause of an acute abdomen in pregnancy. The modern factor of pelvic inammatory disease during preg­nancy is assisted reproductive technology with the inoculation of infective pathogens to the peritoneal cavity. Therefore, techniques for preventing infection inoculation during assisted reproductive technologies are man­datory and discussed in detail. Clinical pre­sentation is the same as in the nonpregnant population with the same differential diagno­ses. Before the widespread use of abdominal sonography, preoperative or prelabor diagno­sis was rare. Abdominal CT or MRI accu­rately denes the type and severity of the pelvic inammatory disease. Accurate stag­ing enables the use of the different therapeu­tic modalities available.
13.1 General Female Population
For an easier understanding of pelvic inamma­tory disease (PID) characteristics in pregnancy, considerations in the general female population are presented.
13.1.1 Tubo-Ovarian Abscess
13.1.1.1 Incidence
Despite increasing the number of broad-spectrum antibiotics, PID and its complications continued to reach epidemic proportions into the 1990s. Acute salpingitis and PID account for more than 350,000 hospital admissions and 150,000 surgi­cal procedures per year [1]. Also, nearly one­third of patients hospitalized for PID develop some degree of pelvic abscess [2]. Other sequels such as ectopic pregnancy, salpingitis isthmica nodosa, tubal infertility, chronic pelvic pain syn­dromes, and pelvic adhesions are other conse­quences of PID (Fig.13.1).
13.1.1.2 Pathophysiology
A tubo-ovarian abscess (TOA) is the most severe manifestation of salpingitis. The intra-abdominal
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_13
331
332
1000
Case rate, cases/100 000
Year
https://t.me/medicina_free
13 Complicated Pelvic Inammatory Disease
Fig. 13.1 Case rates for
Chlamydia trachomatis infection (age, 15–39years), pelvic inammatory disease (age, 15–44years), and ectopic pregnancy (age, 15–44years), British Columbia, Canada, 1992–2009. PID pelvic inammatory disease, EP ectopic pregnancy [3]
rupture of a TOA is potentially life-threatening, with mortality rates as high as 8.6% [4]. PID and subsequent TOA may result whenever bacteria access the upper female genital tract. Under nor­mal circumstances, the fallopian tubes and related pelvic structures are sterile. However, access to the upper genital tract via sexually transmitted diseases or through instrumentation of the uterus may inoculate the uterus with bacteria from the vagina, causing infection. Passive transport and vectors, such as spermatozoa and Trichomonas, assist in the ascending infection from the polymi­crobial vagina and cervix [5]. Once in sufcient numbers and virulence in the upper genital tract, these bacteria initiate an inammatory reaction (endometritis–salpingitis–peritonitis) that results in the signs and symptoms of PID.The rate of a TOA developing from a typical PID ranges from 1–4% [6].
13.1.1.3 Microbiology
TOA is usually polymicrobial, whereas general pelvic infections may often be monomicrobial.
Chlamydia
PID EP
200 400 600 800
1995 2000 2005
TOAs are usually a mixture of anaerobic, faculta­tively anaerobic, and aerobic organisms, with the purest isolated being anaerobes. The most fre­quent isolates from TOAs include a variety of
Enterobacteriaceae, such as E. coli (37%), B. fragilis (22%), and other Bacteroides spp. (26%), Peptostreptococcus spp. (18%), and Peptococcus
spp. (11%) [4, 7]. Sexually transmitted organ­isms such as N. gonorrhoeae and C. trachomatis are usually not present in the abscess but may be recovered from the cervix in one-third of cases. The emergence and recognition of Prevotella
bivia (formerly Bacteroides bivius) and Prevotella disiens as major pathogens in upper female geni-
tal tract infection, combined with data suggesting that increased concentration of anaerobic organ­isms in the vagina is a risk factor for PID, point toward an anaerobic-predominant mixed infec­tion as a cause of PID and TOA.These anaerobic bacteria, such as Bacteroides spp. and Peptostreptococcus spp., are commonly found in high concentrations in the vagina of women with bacterial vaginosis [5].
13.1 General Female Population
https://t.me/medicina_free
333
13.1.1.4 Prevention
Prevention of PID or prepregnancy treatment eliminates or minimized PID complications in pregnancy.
Delay in the treatment of PID is associated
with an increase in the risks of ectopic preg­nancy and tubal factor infertility (LE3),
Antibiotic therapy enables a cure in 80 to 90%
of cases (LE1),
Antibiotic treatment is indicated once the clini-
cal diagnosis of PID is probable after microbi­ological samples are taken (grade A),
Vaginal sampling for microbiological diagno-
sis is recommended before elective termination of pregnancy. (Pelvic inammatory diseases:
Updated French guidelines, 2020 [8]).
13.1.1.5 Clinical Presentation
The clinical diagnosis of TOA has similar diag­nostic difculties as PID. Women presenting with PID and pelvic mass may have a TOA, or it could be a hydrosalpinx, tubo-ovarian complex, or other complex adnexal mass. Patients with TOAs typically present with pelvic or abdominal pain and fever. A history of PID may be present in only 50% of patients. A signicant proportion of women with TOA are afebrile (20–30%) (these have normal WBC counts) [2].
Pelvic examination usually reveals extreme pelvic tenderness (cervical motion tenderness), and mass may be present. If rupture has occurred, typical signs and symptoms of peritonitis are present and may lead to septic shock.
13.1.1.6 Diagnosis
Leukocytosis is common, but afebrile patients can have normal WBC levels [2]. CRP is a sensi­tive, specic inammatory marker for predicting TOA in patients with complicated PID, and levels >50mg/L suggest TOA [9].
Transvaginal ultrasound (US) is reliable for diagnosing and following conservatively man­aged TOAs [7]. A typical appearance is a com­plex or cystic adnexal mass with multiple internal echoes and septations. The “gold standard” for the diagnosis is laparoscopy. However, laparos-
Table 13.1 Major and additive criteria for the diagnosis of PID
Major criteria
The absence of these criteria tends to rule out a PID diagnosis Spontaneous pelvic pain (in the absence of another
disorder) and Induced adnexal pain and/or Pain on uterine mobilization
Additive criteria
Each of these criteria increases the probability of PID History: Sexually transmitted infection; postpartum
or postabortion; recent endouterine maneuvers; rectal
syndrome (tenesmus, other anal spasms); vaginal
bleeding Clinical examination: Temperature>38°C; purulent
leucorrhea Laboratory tests: Elevated C-reactive protein; the
presence of chlamydia trachomatis, Neisseria
gonorrhoeae, or mycoplasma genitalium on
bacteriological examination; endometritis on
endometrial biopsy sample; salpingitis on the
mbrial biopsy sample US: Thickening of the tubal wall (>5mm); cogwheel
sign (thickened tubal fringes resembling incomplete
septa); heterogeneous latero-uterine mass potentially
septated with ne echoes
Reproduced with permission from [10] PID pelvic inammatory disease
copy may be reserved for uncertain diagnoses as US technology improves.
Criteria for PID in the general female popula-
tion apply to the pregnant population (Table13.1).
13.1.1.7 Treatment andPrognosis
Indications for surgery in the treatment of TOA are the same as in the nonpregnant population (see Sect. 13.9). CRP level trends correlate with the success or failure of conservative TOA man­agement. Increasing CRP levels during treatment may be used as an indicator of the need for inva­sive intervention [9].
Intraperitoneal rupture of a TOA represents a true surgical emergency, but the extent of the sur­gery required to achieve a cure is controversial [7, 11]. Traditionally, aggressive surgery, usually total abdominal hysterectomy with bilateral salpingo- oophorectomy and drainage of all pock­ets of infection, was the treatment of choice. This radical approach was common because of the
334
https://t.me/medicina_free
13 Complicated Pelvic Inammatory Disease
Table 13.2 Protocols for antibiotic therapy of uncomplicated PID in the general population
Antibiotics Dose and route Duration Comments
First-line treatment
Ooxacin 400mg twice a day, oral 14days – Metronidazole 500mg twice a day, oral 14days – Ceftriaxone
a
500mg im. Injection
Possible alternatives
Ceftriaxone Azithromycin
b
b
500mg im. Injection
1g per week 14days Limited efcacy against anaerobes Moxioxacin 400mg/day 14days Higher cost; precautions for hepatic disorders Ceftriaxone Metronidazole Doxycycline
Reproduced with permission from [10]
a
Can be used if necessary
b
Used together
c
Used together
c
c
c
500mg im. Injection
500mg twice a day, oral 14days
100mg twice a day, oral 14days
inadequacies of antibiotics at that time. This procedure dropped the mortality rate from 100% to 12% [12] and could be the procedure of choice for a patient who has completed childbearing. In patients with severe complicated disease, total abdominal hysterectomy with bilateral adnexec­tomy may be necessary despite the patient’s reproductive status. Patients without adnexa can still conceive via invitro fertilization and embryo transfer (IVF-ET). Subtotal hysterectomy is another option [13]. Antibiotic therapy should include a broad-spectrum cephalosporin such as cefoxitin or cefotetan. Anaerobic coverage with clindamycin or metronidazole is mandatory, with their excellent ability to penetrate an abscess [7].
However, most women with a TOA are at the peak of their reproductive years, and fertility is a major issue. Conservative surgery should be attempted if the pathology is limited to one side and further reproduction is desired [14]. Conservative therapy of PID (Table13.2) or an unruptured TOA (Table 13.3) consists of appro­priate IV antibiotics [15], close monitoring of the patient, and possible drainage of the abscess via posterior colpotomy [1517], CT- or US-guided percutaneous drainage, or drainage via laparos­copy. The posterior colpotomy approach has largely been abandoned because of a high com­plication rate. CT-guided percutaneous drainage success rates are in the range of 77–94% [18]. Early laparoscopic drainage with irrigation and antibiotics has a success rate of 95% [19].
Table 13.3 Proposed IV antibiotic therapies of tubo­ovarian abscess in the general population
Substance
b
Dosage
a
Duration
c
(days)
First-line treatment
Ceftriaxone 1–2g once a day 14–21 Metronidazoled500mg three times a
14–21
day
+ doxycyclined100mg twice a day
Alternatives
Ooxacin + metronidazole
c
d
400mg twice a day 14–21 500mg three times a
d
day Cefoxitin 1–2g three times a day 14–21 + doxycyclined100mg twice a day
Reproduced with permission from [10]
a
In cases of septic shock, severe sepsis, or immunode-
pression, 3–8mg/kg/d IV gentamicin can be added for no more than 5days
b
Reassessment of the antibiotic therapy at 72h based on
the clinical and microbiological results is essential. In the case of a de-escalation of the antibiotic spectrum, it is rec­ommended that treatment against anaerobic microbes and C. trachomatis continue until the therapy is completed
c
These protocols do not cover all bacteriological situa-
tions (e.g., the resistance of some gonococcal species to uoroquinolones and the resistance of some enterobacte­ria species)
d
Because oral bioavailability is good for ooxacin, metro-
nidazole, and doxycycline, it is possible to administer them orally as soon as the patient is no longer running a fever, has no gastrointestinal disorders, and has shown some clinical improvement
Drainage of a TOA in combination with antibi­otic therapy is much more successful than con­servative management. Patients treated with
13.2 Historical Considerations
https://t.me/medicina_free
335
antibiotics alone have a 50–70% success rate. The remaining patients eventually require surgi­cal treatment [2, 5, 20]. Approximately 19% of conservatively treated patients require reopera­tion later [2, 20, 21]. Some advocate early surgi­cal intervention for TOA, with the highest success rate (96.8%) and the lowest risk of readmission within 12 months (16.1%) [22]. Others recom­mend for patients above 40 years, febrile, and have a larger TOA, primary drainage at presenta­tion [23]. In cases of grossly apparent bilateral disease, a somewhat conservative approach of bilateral partial adnexectomy without hysterec­tomy may be performed.
13.1.2 Ovarian Abscess
13.1.2.1 Historical Perspective
William T. Black presented the rst major series of 105 cases in 1936 [24]. Streptococcus spp. was found in 95%. The incidence of OA from all cases of PID was 6%, while other cited authors in that study claimed 12.4–15.45%. Wetchler and Dunn collected 120 cases in females until 1985 [25], and Stubbleeld added ve cases in 1991 [26].
13.1.2.2 Pathophysiology
OA is a primary infection of the parenchyma of the ovary, an entity distinctly different from TOA.TOA, by contrast, involves the ovary by sec­ondary spread from the infected fallopian tube [25]. Ascending infection is the most important mode of infection in nonpregnant women. OA has also been reported due to non-gynecologic condi­tions such as acute perforated appendicitis, colonic diverticulitis, distant infection from tonsillitis, typhoid, parotitis, and tuberculosis. Association of OA with an intrauterine device (IUD) has been noted, and some may be secondary to Actinomyces spp. [27, 28]. It may also occur due to a secondary infection in a dermoid cyst, serous cystadenoma, or a simple ovarian cyst.
13.2 Historical Considerations
In the sixth edition of Antenatal and Postnatal Care, Francis J.Browne, in 1946 [29], stated that
salpingitis does not occur during pregnancy. Even in that era, and decades before this sixth edition, cases of PID during pregnancy were pub­lished [3040]. Auguste (Marie Joseph Victor) Brindeau (Fig.13.2) published the rst cases in
1917. He reported a case of fatal peritonitis from OA rupture immediately after a term delivery [42]. In addition to 12 personal cases of salpingo­oophoritis during pregnancy, Brindeau collected 81 more cases. Of these, 44 were operated on [35]. Up to 1939, he added 23 personal cases [35]. These cases, not described in detail, were reported as being of an “unprecise nature.” In many, if not all, the etiology was implied to be criminal interference. Aleck W.Bourne, in 1921, made detailed pathophysiology and progression of acute puerperal salpingitis [43]. French gyne­cologists also added to this subject at that time— Auvray in 1925 [39], Fruhinsholz, Hamant, and Mosinger in 1929 [44], Devraigne and Ravina in 1937 [45], Bidoire in 1939 [34], and Metzger in 1939 [46]. Their cases occurred about the second month of pregnancy, sometimes earlier, and were almost invariably diagnosed as ectopic pregnancy or acute appendicitis.
Lauchlan Aitken, in 1870, made the rst description of a ruptured primary ovarian abscess (OA) during premature labor in the seventh month of pregnancy, with fetal and maternal death [47]. Then HC Coe, in 1891, described three cases. One had an OA rupture into the uri­nary bladder and later delivered a viable infant [48]. KH Öhman, in 1913, operated on 7 days after an uneventful delivery due to acute pelvic symptoms with a mass to one side, which proved to be a streptococci pyo-ovarium [40]. Tenani, in 1921, reported the rupture of a pyo-ovarium dur­ing the second stage of labor [49]. Pomini, in 1939, described a ruptured OA on the fth day following a rapid, uneventful delivery [50].
336
https://t.me/medicina_free
13 Complicated Pelvic Inammatory Disease
Fig. 13.2 Auguste (Marie Joseph Victor) Brindeau, a French gynecologist (1867–1955), worked in Paris, nally at the Clinique Tarnier, where he retired. One of the
13.3 Incidence
13.3.1 Acute Salpingitis
Acute salpingitis in pregnancy is rare. Metzger, in 1939, made a 15-year review of French litera­ture and found only seven references [46]. Up to 1959, all reported cases (12 cases) occurred in the rst half of pregnancy [51]. Recent cases con­rmed salpingitis as early as the peri- implantation period [52]. Acute salpingitis is more common during the rst trimester [53]. The average mean gestational age for PID is 19weeks [54]. It prob­ably occurs earlier but is diagnosed during the second trimester.
13.3.2 Tubo-Ovarian Abscess
PID, in the form of a pelvic and peritoneal abscess, rarely complicates pregnancy for several reasons. First, in cases of a wanted pregnancy, future mothers live healthy life avoiding any risks, including sexually transmitted diseases.
founding members of the journal Gynécologie et Obstétrique in 1919. (Reproduced with permission from [41]; webpage Biusanté Paris)
Second, women with “gynecological problems” visit gynecologists more often to eliminate any possibility of interfering with a future pregnancy. Diseases during the prepregnancy period are cured, minimizing the possibility of disease are during pregnancy. Third, women during gestation use protection more often. Fourth, the cervical mucus plug and intact amniotic membrane pro­tect against ascending infection.
Acute salpingo-oophoritis or pelvic abscess mainly occur early after transvaginal oocyte retrieval (TVOR) [55] or in the rst trimester [56,
57] and is almost always on the right side [58, 59]. There is no side predilection in IVF-ET
because TOA starts on the side of TVOR.Up to 2021, at least 44 cases of TOA were published [6067]. Pelvic infection readily occurs or pres­ents in the puerperium if there is an infection of the birth canal during or following parturition [61]. Pelvic infection after TVOR for IVF-ET is <0.6% [6871]. A pelvic abscess develops in <50% of these cases [69]. Up to 1959, 20 cases were collected, with bilateral TOA present in 50% of cases [51].
13.4 Etiopathogenesis
https://t.me/medicina_free
337
13.3.3 Ovarian Abscess
Although the true incidence of OA in pregnancy is unknown, it seems it is extremely rare [25, 27,
40, 4749, 51, 7281]. According to Dudley
etal., the ratio of OA to TOA is increased in preg­nancy [58].
13.3.4 Intramyometrial andUterine Horn Abscess
These entities are not described as part of PID, but it is mentioned here due to the same possible etiological factors. These are the rarest entities, with only one report for both intramyometrial (two cases) [82] and uterine horn abscess [83] found.
13.4 Etiopathogenesis
The extension of the inammation by simple conti­guity from the pelvic to the abdominal peritoneum is especially liable to occur in cases of puerperal pelvi-peritonitis at about the end of the second week when the patient has not taken sufcient care of herself.
(Gustave Bernutz)
Sometimes a pus tube forms after conception has occurred, the woman having been infected and impregnated at the same time.
(Joseph Bolivar Delee, 1938 [84])
13.4.1 Suppurative Salpingitis
13.4.1.1 Acute Suppurative Puerperal
Salpingitis
Aleck W. Bourne, in 1921 described acute puer­peral salpingitis, which differs in many aspects from that of non-puerperal origin [43]. By the end of the rst week, when symptoms manifest, the fal­lopian tubes lie at or just above the pelvic brim near the iliac vessels. At the same time, the ovaries are placed below, just within the pelvis, and applied to its lateral walls. The former is, therefore, outside the limitation of the pelvic basin, surrounded by coils of the small intestine; this considerably alters
the results which will follow the escape of pus from the abdominal ostia, as compared with a similar tubal condition in which the tubes are lodged within the pelvic cavity. In the latter case, the resulting abscesses are strictly circumscribed in the pouch of Douglas, and the whole inammatory area tends to be roofed in and delimited by the omentum or small intestine. The general extension of the infection into the abdominal peritoneum is unusual, and the symptoms and signs are corre­spondingly localized. Resolution is a frequent result; the patient recovers without operation and may regain a fair state of health. However, condi­tions differ in puerperal salpingitis. The abdominal location of the tubes is the cause of abdominal, not pelvic peritonitis, since it allows the outpouring of pus among the coils of the small intestine at or just above the level of the sacroiliac joint, and herein lies the essential difference between the two variet­ies of salpingitis. This difference manifests as much in the physical signs exhibited as in the treat­ment required. Further, the hyperthermic condition of the uterus and appendages during the puerpe­rium will also modify the gravity of the symptoms and the rapidity of their course.
The involution of the uterus appears to be arrested at a point at which the fundus extends about halfway between the symphysis and the umbilicus. This may be due to infection within its cavity or possibly to a neighboring active suppura­tion in the tubes. However, the important result is that the tubes are maintained at their high level at or above the pelvic brim for a considerable time after the inception of the disease. Moreover, the large uterus nearly lls the pelvic cavity and affords a xed point comparatively high up in the abdomen, proper for developing adhesions with other parts.
In the acute stage, the tubes are greatly con­gested and edematous, especially the ampullary portion, while the mbriae are protruding, and the ostium is discharging pus. The isthmus may appear quite normal or swollen to a lesser extent. Any adhesions at rst are light and easily sepa­rated, often due to akes of recent lymph and chiey involving adjacent coils of the small intestine and part of the cecum or sigmoid colon.
The abdominal ostium frequently opens into a small abscess cavity walled in by the adherent coils
338
https://t.me/medicina_free
13 Complicated Pelvic Inammatory Disease
and situated at rst just in front of and above the sacroiliac joint. Later, when suppuration has extended, it tends to pass forward along the brim of the pelvis toward the uterine corn and is shut in from above by the greater omentum, or the pus may even come into relation with the abdominal wall.
13.4.1.2 Acute Salpingitis
A risk factor for acute salpingitis is an ectopic pregnancy or vice versa. Coues of Boston, in 1911, reported 214 ectopic pregnancies with 16% of mild catarrhal salpingitis in the opposite fal­lopian tube. Other etiopathogenetic factors are the same as in TOA (see Sect. 13.4.2).
13.4.2 Tubo-Ovarian Abscess
During pregnancy, pelvic infection occurs inde­pendently of the gravid state, or the infection may exist before the pregnancy. Friedman and Bobrow have proposed four mechanisms for OA or TOA during pregnancy [51] as follows:
• Hematogenous spread as in pelvic tuberculosis,
• Lymphatic spread, especially from the vagina and cervix,
• Infection of a (previously) existing ovarian cyst,
• A are-up of an old infection.
Metzeger described similar mechanisms in
1939 [36] as follows:
When infection occurs during fertilization, attachment and detachment of gonococci to human sperm occur. The gonococcus acts as a “hitchhiker” on the traveling sperm until a favor­able environment for detachment is encountered, such as in the uterus or fallopian tube [85]. Different pathogens have susceptibility to spe­cic routes of infection and its spread. Gonorrheal PID is often bilateral by ascending infection, while tuberculosis PID results from hematoge­nous infection [51].
13.4.2.1 In Vitro Fertilization–Embryo
Transfer
TOA is a rare complication of TVOR, which usu­ally fails. It occurs in 0.2–0.5% of TVOR [68,
86], but 32% of all OA were after TVOR [60].
Three different pathways for inoculation are described [70, 87, 88] as follows:
• Inoculation of vaginal microorganisms and anaerobe opportunists by puncture through the non-sterile vagina,
• Reinfection through puncture of chroni­cally infected ovaries,
• Infection through direct bowel puncture with an inammatory or infectious spillage.
Techniques to decrease the risk of pelvic
infection include [86, 8992] the following:
• Infection at the time of fertilization,
• Infection soon after fertilization before the uterine cavity has become closed by conception (12weeks),
• Vascular or lymphatic spread (from a septic focus in the vagina or cervix),
• A are-up of preexisting infection,
• Instrumentation sufcient to overcome natural barriers,
• Ascending infection associated with threatened abortion and intrauterine bleeding.
• The fewest possible vaginal punctures (2 max.),
• Vaginal preparation (0.5% saline or 10% povidone-iodine),
• Prophylactic antibiotics (IV cefazolin).
Prophylactic antibiotics following TVOR are controversial as pelvic inammation is uncommon, and these medications may not pre­vent all associated infections. Antibiotic pro­phylaxis is recommended in groups with a higher risk for infection (see Sects. 13.4.2.2 and 13.4.2.3).
13.4 Etiopathogenesis
https://t.me/medicina_free
339
13.4.2.2 In Vitro Fertilization–Embryo Transfer andEndometriosis
Endometriosis/endometrioma is a risk factor for PID and TOA/OA development following TVOR [64, 66, 9395]. Up to 80% of PID following TVOR had underlying endometriosis [69]. Among its risk factors, incidental aspiration of an ovarian endometrioma during TVOR activates the pelvic infection [93, 96, 97]. Old blood in endometrioma provides a culture medium for bacteria to grow slowly after transvaginal inocu­lation. This explains the role of endometriosis in predisposing patients to PID [93]. Endometriotic pseudocapsule and old blood inside may prevent antibiotic prophylaxis from overcoming the transvaginal bacterial inoculation [93]. Furthermore, the altered immune system of a patient with endometriosis might fail to over­come the inoculated bacteria [69].
Previous reports had indicated that aspiration of endometriotic cysts before ovulation induction for ART resulted in a better clinical outcome [98]. To prevent infection in patients with endo­metrioma undergoing TVOR, the endometrioma should be aspirated before TVOR [99]. However, these endometriotic cysts reexpand quickly after aspiration, and it is difcult to harvest some oocytes without puncturing through these choco­late cysts. In addition, the chocolate content of the follicular uid is sometimes found inciden­tally after aspiration [100]. Endometriosis sur­gery does not affect ART outcomes and does not increase unresponsiveness to ovarian stimulation [101]. Moreover, the ovarian reserve may be adversely affected by the surgical excision of endometrioma [102].
Endometriosis is a risk factor for develop-
ing a TOA or an OA [95]. Infection-
preventing measures should be applied not
only before and immediately after
TVOR.The excision of endometrioma less
than <4 cm in diameter is discouraged
before ART [103, 104].
13.4.2.3 Previous Pelvic Inammatory Disease
The risk of infection is higher in cases of previ­ous PID [70, 88, 105107]. Unilateral TOA may be explained by a “are-up” of preexisting but latent salpingitis [108]. This possibility would seem to necessitate a low-grade infection of the fallopian tube in the rst instance leaving suf­cient patency to permit the passage of a fertilized ovum. After nidation, the infection may become acute, probably because of the congestion pro­duced by the gestation or unilateral salpingitis, the other fallopian tube being patent and func­tioning [109]. Another proof of a “are-up” of the previous infection is an intraoperative nding of adhesions between the loops of the intestine, the uterus, and the tubo-ovarian tissue indicating the chronic nature of the disease [110].
Pelvic actinomycosis is considered a genuine, albeit exceedingly rare, hazard of IUD. In one study from the general female population, all 12 cases of OA were associated with IUD use, and some were of actinomycotic origin [25]. As an IUD-related pregnancy complication, ovarian actinomycosis is even more exceptional, and a history of IUD is common [27, 28]. The IUD colonizes the endometrium, from where the bac­teria proceed through the tube and into the perito­neal cavity, eventually gaining access to the ovarian substance at ovulation. Why actinomy­cotic involvement of the fallopian tube some­times does not occur is unclear unless the dissemination of A. israelii is blood-borne or lymphatic rather than the result of ascending infection.
During the rst half of the twentieth century, tuberculous salpingitis with intrauterine preg­nancy was more frequent [111]. The frequency with which pregnancy occurs in the presence of pelvic tuberculosis is difcult to assess for the following reasons: (1) The incidence of unsus­pected pelvic tuberculosis in apparently healthy females is unknown; (2) pelvic tuberculosis may be discovered after pregnancy has occurred; (3) in proved cases of pelvic tuberculosis, pregnancy has rarely been reported.